Time from reperfusion | Pairwise comparison (P value) | |||||
---|---|---|---|---|---|---|
< 3 h | 24 h | 6 days | A* | B* | C* | |
Ejection fraction (EF) (%) | 49 ± 11 | 48 ± 11 | 51 ± 9 | 0.66 | 0.45 | 0.21 |
End Diastolic Volume (EDV) (ml) | 162 ± 33 | 168 ± 33 | 177 ± 29 | 0.11 | 0.001 | 0.015 |
End Systolic Volume (ESV)(ml) | 83 ± 27 | 89 ± 27 | 89 ± 24 | 0.085 | 0.057 | 1.0 |
Late gadolinium enhancement (LGE) (LV %) | 27 ± 16 | 26 ± 16 | 27 ± 19 | 1.0 | 0.99 | 0.87 |
Microvascular obstruction (MVO) (LV %) | 4.0 ± 4.9 | 4.1 ± 6.0 | 2.4 ± 3.4 | 1.0 | 0.02 | 0.011 |
MVO prevalence (n, %) | 11 (44%) | 17 (56%) | 12 (55%) | – | – | – |
Intra-myocardial haemorrhage (IMH) mm2 | 0.7 ± 1.6 | 1.4 ± 1.6 | 1.1 ± 1.4 | 0.012 | 0.46 | 0.69 |
IMH prevalence (n, %) | 9 (36%) | 14 (47%) | 10 (45%) | – | – | – |